1. Egypt has a large installed base for Blood Gas Analyzers owing to the presence of ~2000+ hospitals in the country
Egypt’s expanding healthcare infrastructure is driving the growth of the Blood Gas, POC Immunoassay Analyzer, and Transcutaneous Monitoring Devices Market. The medical devices industry in Egypt is a highly import-driven industry in Egypt as there is a very limited production of medical devices in the country. Along with it, the diagnostic equipment market is witnessing an increment in the Consumable sales model as Hospitals are now preferring to rent the equipment instead of purchasing it. Egypt’s expanding healthcare infrastructure has drawn significant firms from across the world to address the country’s rising need for blood gas and POC immunoassay analyzers, as well as transcutaneous monitoring equipment.
2. Implementation of Digital Solutions, Integration with HIS/LIS, Dependency on POC Devices and AI will be the future of Blood Gas Analyzers
The interface with the HIS/LIS will expedite the testing procedure, resulting in cost savings. This integration would also improve, providing a full clinical picture across the care continuum. In addition to this, a digital diagnostic system has been created that allows doctors to receive data for arterial blood gas readings from patients with respiratory or metabolic problems via a simpler, less invasive venous puncture using a digital algorithm. Furthermore, the next generation of point-of-care devices would be wireless, allowing for thorough blood analysis testing with findings in under a minute. Caregivers, patients, and hospital management all gain from faster turnaround time, patient care, and operational efficiencies when testing is moved to the patient’s side.
Request For Sample Report @ https://www.kenresearch.com/sample-report.php?Frmdetails=NTA0MjA1
3. Demand for Fully Automated devices, new testing techniques, and an Increased testing menu will be the future of POC Benchtop IAA devices
Companies are continuously focusing on developing their IAA devices to increase their testing parameters and provide an exhaustive testing menu for a single device. Growing preference for automated instruments in hospitals and laboratories will significantly improve the efficiency and quality of testing in the country. These products can meet the increasing demand for quality diagnostic testing despite of staff shortage, a commonly faced problem by hospitals and laboratories. New techniques for testing are being developed by manufacturers to broaden their testing parameters. AI will have the potential to improve operational efficiency, freeing up experts from repetitive and mundane tasks.
Request For customization @ https://www.kenresearch.com/ask-customization.php?Frmdetails=NTA0MjA1
4. Handling the Reagents, Low Awareness of Devices, Delay in Delivery of the devices are some of the major challenges faced in the industry
Reagents usually have a limited shelf life and sometimes require temperature-sensitive storage which adds to the maintenance cost for the Blood Gas and Immunoassay Analyzer devices. This creates a challenging situation for both the Manufacturer and Distributor as the end users tend to demand discounts or cheap costing reagents. Moreover, end users are confused between devices with invasive and non-invasive techniques performing tests on older equipment. Delivering a BGA, IAA or TCM device takes a process of 2-2.5 months as all the products are imported from other countries. Majority of the time is taken up by custom clearance as separate approvals are required from Ministry of Health and Police department.
For more insights on the market intelligence, refer to below link:-